Hypothalamic hamartoma

Revision as of 01:57, 18 April 2009 by Adeeljamil (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Hypothalamic hamartoma

Articles

Most recent articles on Hypothalamic hamartoma

Most cited articles on Hypothalamic hamartoma

Review articles on Hypothalamic hamartoma

Articles on Hypothalamic hamartoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hypothalamic hamartoma

Images of Hypothalamic hamartoma

Photos of Hypothalamic hamartoma

Podcasts & MP3s on Hypothalamic hamartoma

Videos on Hypothalamic hamartoma

Evidence Based Medicine

Cochrane Collaboration on Hypothalamic hamartoma

Bandolier on Hypothalamic hamartoma

TRIP on Hypothalamic hamartoma

Clinical Trials

Ongoing Trials on Hypothalamic hamartoma at Clinical Trials.gov

Trial results on Hypothalamic hamartoma

Clinical Trials on Hypothalamic hamartoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hypothalamic hamartoma

NICE Guidance on Hypothalamic hamartoma

NHS PRODIGY Guidance

FDA on Hypothalamic hamartoma

CDC on Hypothalamic hamartoma

Books

Books on Hypothalamic hamartoma

News

Hypothalamic hamartoma in the news

Be alerted to news on Hypothalamic hamartoma

News trends on Hypothalamic hamartoma

Commentary

Blogs on Hypothalamic hamartoma

Definitions

Definitions of Hypothalamic hamartoma

Patient Resources / Community

Patient resources on Hypothalamic hamartoma

Discussion groups on Hypothalamic hamartoma

Patient Handouts on Hypothalamic hamartoma

Directions to Hospitals Treating Hypothalamic hamartoma

Risk calculators and risk factors for Hypothalamic hamartoma

Healthcare Provider Resources

Symptoms of Hypothalamic hamartoma

Causes & Risk Factors for Hypothalamic hamartoma

Diagnostic studies for Hypothalamic hamartoma

Treatment of Hypothalamic hamartoma

Continuing Medical Education (CME)

CME Programs on Hypothalamic hamartoma

International

Hypothalamic hamartoma en Espanol

Hypothalamic hamartoma en Francais

Business

Hypothalamic hamartoma in the Marketplace

Patents on Hypothalamic hamartoma

Experimental / Informatics

List of terms related to Hypothalamic hamartoma

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Hypothalamic hamartoma (abbreviated as HH) is a congenital condition consisting of a mass of disorganized neuronal or glial tissue on or near the hypothalamus. HH is generally not detected on CT scans, and on MRI it is isointense to gray matter. The size of HHs varies from less than 1 cm to more than 3 cm. It is estimated that HH occurs in about one out of a million or two million individuals. These lesions can be pedunculated or sessile, a distinction that carries with it some differences in presenting symptoms.

The classic HH presenting syndrome is that of gelastic, or laughing, epilepsy, often mixed with other kinds of seizures; precocious puberty; and behavioral disorders. The seizures often begin when the patient is very young, although studies have shown that the onset of epilepsy can occur in adulthood. In HH, the seizures are now known to originate in the hamartoma itself, and the lesion is considered to be “intrinsically epileptogenic.” In the past, these seizures have been localized to other parts of the brain, including the temporal lobe, and sometimes resections of other brain tissue have been carried out, to poor results. Current thinking is that as the hamartoma generates constant seizures in one part of the brain, the neocortex learns to generate seizures on its own, leading to many different kinds of seizures. These seizures can have an antagonistic relationship with the characteristic behavioral disorders, which include aggressive behavior, also known as “hypothalamic rage.” Cognitive decline is often present, as manifested by poor school performance and socialization.

HH may be associated with Pallister-Hall syndrome, which is a syndrome consisting of multiple malformations, including polydactyly and imperforate anus. HH in Pallister-Hall syndrome causes less severe neurological symptoms than isolated cases of HH. Patients with isolated hamartomas often find that standard anticonvulsant treatments do not stop their seizures, leading many patients to consider surgery.

Classically, surgical resection of HH has produced poor results, with no or little reduction in seizures or behavioral disorders, and some patients have developed panhypopituitarism, which can be fatal if untreated. More recently, surgical centers such as the Barrow Neurological Institute have begun treating patients with HH, and new surgical techniques, such as the endoscopic or transcallosal approaches, have produced much better results. When these surgical techniques are used, there is often a reduction of seizure activity and behavior problems, and fewer hormonal side effects. Surgery to remove the hamartoma can also help reverse precocious puberty and the cognitive problems that affect many of the children with this disorder.

External links

Citation: A Note on Gelastic Epilepsy. J.M.S. Pearce. European Neurology 2004;52:172-174 Template:SIB

Template:WH Template:WikiDoc Sources